Cormorant Asset Management’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Cormorant Asset Management’s Portfolio ONSIW Stock Details ONSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-416,666	Closed	-$9K	–	78
2018 Q3	$9K	Hold	416,666	–	–	﹤0.01%	64
2018 Q2	$20K	Hold	416,666	–	–	﹤0.01%	57
2018 Q1	$15K	Hold	416,666	–	–	﹤0.01%	51
2017 Q4	$13K	Hold	416,666	–	–	﹤0.01%	50
2017 Q3	$51K	Hold	416,666	–	–	0.01%	49
2017 Q2	$72K	Hold	416,666	–	–	0.01%	69
2017 Q1	$333K	Hold	416,666	–	–	0.05%	72
2016 Q4	$79K	Hold	416,666	–	–	0.01%	75
2016 Q3	$199K	Hold	416,666	–	–	0.02%	79
2016 Q2	$192K	Buy	+416,666	New	+$160K	0.03%	81

Cormorant Asset Management's ONSIW Position: Q4 2018 in Review

Cormorant Asset Management sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2018, closing a stake of 416,666 shares — an estimated $9K sold.

Cormorant Asset Management first reported a position in ONSIW in Q2 2016 and held it in 10 quarters. The position peaked at $333K in Q1 2017. 0 funds tracked by Wall St. Rank hold ONSIW as of Q4 2018.

Cormorant Asset Management reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2018 after selling out during the quarter.
Cormorant Asset Management sold 416,666 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2018, an estimated $9K.
Cormorant Asset Management first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 10 quarters.
Cormorant Asset Management's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $333K in Q1 2017.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2018.

Based on Cormorant Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.